SearchDictionaryMobileLogin

P Rutgeerts Selected Research

infliximab (Remicade)

08/2008Infliximab for pediatric Crohn's disease.
04/2006Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literature.
02/2006Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
10/2005Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
07/2005The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
09/2004Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
08/2004Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
04/2004The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
03/2004Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease.
10/2002Infliximab for ulcerative colitis: the need for adequately powered placebo-controlled trials.
07/2002A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism.
04/2001Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.
05/2000Infliximab is the drug we have been waiting for in Crohn's disease.

Articles by Research Topic

Disease

34Crohn Disease (Crohn's Disease)
08/2008 - 02/2000
9Ulcerative Colitis
11/2006 - 02/2001
8Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2006 - 04/2000
3Colitis
11/2006 - 05/2001
3Inflammation
07/2002 - 05/2001
2Colorectal Neoplasms (Colorectal Cancer)
11/2005 - 05/2000
2Necrosis
08/2004 - 11/2001
1Miliary Tuberculosis
04/2006
1Aneuploidy (Aneuploid)
11/2005
1Major Depressive Disorder (Major Depressive Disorders)
07/2005
1Granuloma
02/2005
1Gastroesophageal Reflux (GERD)
02/2005
1Hemorrhage
04/2001
1Varicose Veins (Varicose Vein)
04/2001
1Endometriosis (Adenomyosis)
02/2000

Drug/Important Bio-Agent (IBA)

13infliximab (Remicade)FDA Link
08/2008 - 05/2000
6Interleukin-10 (Interleukin 10)IBA
02/2002 - 12/2000
2AntibodiesIBA
11/2006 - 09/2005
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
05/2006 - 10/2001
2Budesonide (Pulmicort)FDA LinkGeneric
02/2001 - 02/2001
1adalimumab (Humira)FDA Link
09/2007
1daclizumab (dacliximab)FDA Link
11/2006
1Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2006
1Ribosomal DNA (rDNA)IBA
08/2006
1DNA (Deoxyribonucleic Acid)IBA
11/2005
1Phenobarbital (Luminal)FDA Link
10/2005
1Proton Pumps (Proton Pump)IBA
02/2005
1Pattern Recognition ReceptorsIBA
02/2005
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2004
1Fc Receptors (Fc Receptor)IBA
03/2004
1Immunoglobulin G (IgG)IBA
03/2004
1Interleukin-18 (Interleukin 18)IBA
02/2004
1Interferon-alpha (Interferon Alfa)FDA Link
12/2003
1interferon beta 1aFDA LinkGeneric
09/2003
1recombinant human tumor necrosis factor-binding protein-1IBA
01/2003
1Interleukin-1 (Interleukin 1)IBA
11/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2002
1Interferon-gamma (Interferon, gamma)IBA
02/2002
1Indomethacin (Indometacin)FDA LinkGeneric
11/2001
1TenascinIBA
10/2001
1ridogrelIBA
09/2001
1TNFR-Fc fusion protein (etanercept)FDA Link
09/2001
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2001
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2001
1Interleukin-12 (IL 12)IBA
05/2001
1Mesalamine (Mesalazine)FDA LinkGeneric
04/2001
1CCR5 Receptors (CCR5 Receptor)IBA
03/2001
1AutoantibodiesIBA
03/2001
1SteroidsIBA
02/2001
1Technetium Tc 99m Exametazime (Ceretec)FDA Link
02/2001
1Interleukin-15 (Interleukin 15)IBA
04/2000
1Carbon MonoxideIBA
02/2000

Therapy/Procedure

1Balloon Dilatation
11/2004
1Ligation
04/2001
1Laser Therapy (Surgery, Laser)
05/2000